Melanoma

 

Vemurafenib for Metastatic Melanoma Patients With Brain Metastases
An Open-label, Single-arm, Phase II, Multicenter Study, to Evaluate the Efficacy of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases

Investigator: Kim Margolin, M.D.;   Conditions: Malignant Melanoma;    Status: Recruiting;   Study ID: NCT01378975